Spices from India recalled, FDA issues import detention notice
|
The FDA has analyzed samples of three products, Everest Garam Masala, Everest Sambhar Masala, and Maggi Masala ae Magic, and the results showed the products were contaminated with Salmonella.
|
|
|
New Import Regulations introduced in Gambia for Drugs – Pre Shipment Inspections – Product Testing related
|
The Medicines Control Agency (MCA), The Gambia has introduced the regulation of pre- shipment document verification, physical inspection, quality control testing and issuance of Clean Report of Inspection and Analysis (CRIA) for Pharmaceuticals to address issues related to substandard and falsified (counterfeit) medicines entering the country.
|
|
|
USP sets up a programme unit team on excipients with a mandate for fiscal 2024 on specific areas of DEG and EG
|
The United States Pharmacopoeia (USP) has set up a programme unit team on excipients with a mandate for fiscal 2024 on the specific areas of di-ethylene glycol (DEG) and ethylene glycol (EG). The plan envisages contributing in testing excipients and also helping enhance criticality of testing methods in collaborations with USP headquarters in the US
|
|
|
SaSPinjara sees Indian pharma needs ample guidance for China market entry going by regulatory approval challenges
|
SaSPinjara Life Sciences, the technical and business consultation provider for the pharma business in the global market, now sees that for Indian companies, China regulation is still very complex. Only companies with experience in the Chinese market have a certain advantage.
|
|
|
DCGI in talks with global consultants to rationalise drug regulations to ensure quality
|
In order to achieve quality, compliance and patient safety, the Central Drugs Standard Control Organisation (CDSCO) is rationalising the drug regulations in consultation with global regulatory experts. This, according to the Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi, will be done towards ease of doing business and developing a quality culture.
|
|
|
US telemedicine platform ‘Drs.OnCalls’ enters India to offer consultation with doctors globally 24x7
|
Drs.OnCalls, a leading telemedicine platform based in the United States, has announced its strategic expansion into the Indian market. Having successfully established its presence in multiple countries, Drs.OnCalls brings a wealth of expertise and experience to India's growing telemedicine sector.
|
|
|
Import of medical devices to India declines 3.3% in 2022-23
|
Imports of medical devices to India have registered a slight decline of 3.3 per cent during the financial year 2022-23 as compared to the previous year, with the imports from China declining almost 20 per cent.
|
|
|
South India’s premier pharma expo ‘Pharmac South’ to be held at Chennai Trade Centre on July 14 and 15
|
The pharma B2B event hosted by the Indian Drug Manufacturers’ Association Tamil Nadu chapter (TN IDMA) every year in Chennai will be held at the Chennai Trade Centre on July 14 and 15 this year with participation of a wide range of stakeholders of the sector.
|
|
|
|
THERE IS NO BETTER WAY. The One and Only Organisation in India Certified as per International Standards ISO9001:2015 for Consumer Complaint Redressal Services.
|
Write to us today at bejonmisra@jagograhakjago.com to know the suggestions submitted to the Government of India by Consumer Online Foundation on Consumer Protection (E-Commerce) Rules, 2020 & Consumer Protection (Direct Selling) Rules, 2021
|
|
|
|